Cannabis clinical trials at UC Cancer

• THC Crossover Study

  open to eligible people ages 21 years and up

  This is a randomized, crossover study enrolling experienced dual cannabis-tobacco smokers (N=18) to describe the differences in THC and toxicant exposure, examining pharmacokinetic, subjective, and cardiovascular effects from smoking and vaping dry herb cannabis. This study will also examine the differences in toxicant exposure and cardiovascular disease risk between smoking cannabis and smoking tobacco cigarettes.

  at UCSF

Last updated: November 2, 2020